Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma
NCT05518994
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Astrocytoma of Brain
Interventions
DRUG:
Tislelizumab plus Bevacizumab
Sponsor
Henan Provincial People's Hospital